Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)

doi:10.1007/s00520-022-07103-5

Editorial

. 2022 Sep;30(9):7067-7077.

doi: 10.1007/s00520-022-07103-5.

Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)

Hartmut Link¹

Affiliations

PMID: 35739328
PMCID: PMC9225876
DOI: 10.1007/s00520-022-07103-5

Editorial

Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)

Hartmut Link. Support Care Cancer. 2022 Sep.

. 2022 Sep;30(9):7067-7077.

doi: 10.1007/s00520-022-07103-5.

Author

Hartmut Link¹

Affiliation

¹ , Kaiserslautern, Germany. hlink@kabelmail.de.

PMID: 35739328
PMCID: PMC9225876
DOI: 10.1007/s00520-022-07103-5

No abstract available

PubMed Disclaimer

Figures

**Fig. 1**
Synopsis of international guidelines on the prophylactic use of G-CSF; additional risk factors mentioned by ASCO guidelines: advanced disease, poor performance status or poor nutritional status, cardiovascular disease multiple comorbid conditions HIV infection [23]. Secondary prophylaxis is indicated if neutropenia complications occurred without G-CSF or neutropenia-related cycle delays were necessary. Assessment is required after each cycle of chemotherapy.

See this image and copyright information in PMC

Cited by

Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma.
Etzion O, Bareket-Samish A, Yardeni D, Fishman P. Etzion O, et al. Biomedicines. 2024 Apr 11;12(4):848. doi: 10.3390/biomedicines12040848. Biomedicines. 2024. PMID: 38672201 Free PMC article. Review.
Efbemalenograstim alfa, an Fc fusion protein, long-acting granulocyte-colony stimulating factor for reducing the risk of febrile neutropenia following chemotherapy: results of a phase III trial.
Glaspy J, Bondarenko I, Burdaeva O, Chen J, Rutty D, Li R, Wang S, Hou Q, Li S. Glaspy J, et al. Support Care Cancer. 2023 Dec 16;32(1):34. doi: 10.1007/s00520-023-08176-6. Support Care Cancer. 2023. PMID: 38103088 Free PMC article. Clinical Trial.
Safety and efficacy of G-CSF after allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide: clinical and in vitro examination of endothelial activation.
Escribano-Serrat S, Pedraza A, Suárez-Lledó M, Charry P, De Moner B, Martinez-Sanchez J, Ramos A, Ventosa-Capell H, Moreno C, Guardia L, Monge-Escartín I, Riu G, Carcelero E, Cid J, Lozano M, Gómez P, García E, Martín L, Carreras E, Fernández-Avilés F, Martínez C, Rovira M, Salas MQ, Díaz-Ricart M. Escribano-Serrat S, et al. Bone Marrow Transplant. 2024 Oct;59(10):1466-1476. doi: 10.1038/s41409-024-02388-y. Epub 2024 Aug 8. Bone Marrow Transplant. 2024. PMID: 39117736
Comparative Effects of Efavirenz and Dolutegravir on Metabolomic and Inflammatory Profiles, and Platelet Activation of People Living with HIV: A Pilot Study.
Roux CG, Mason S, du Toit LDV, Nel JG, Rossouw TM, Steel HC. Roux CG, et al. Viruses. 2024 Sep 14;16(9):1462. doi: 10.3390/v16091462. Viruses. 2024. PMID: 39339938 Free PMC article.
Delivery of DNA-Based Therapeutics for Treatment of Chronic Diseases.
Sussman C, Liberatore RA, Drozdz MM. Sussman C, et al. Pharmaceutics. 2024 Apr 13;16(4):535. doi: 10.3390/pharmaceutics16040535. Pharmaceutics. 2024. PMID: 38675196 Free PMC article. Review.

See all "Cited by" articles

References

1. Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelsmann R, et al. Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci. 1985;82(5):1526–1530. doi: 10.1073/pnas.82.5.1526. - DOI - PMC - PubMed
1. Welte K, Gabrilove J, Bronchud MH, Platzer E, Morstyn G. Filgrastim (r-metHuG-CSF): The first 10 years. Blood. 1996;88(6):1907–1929. doi: 10.1182/blood.V88.6.1907.bloodjournal8861907. - DOI - PubMed
1. Metcalf D. The colony-stimulating factors and cancer. Cancer Immunol Res. 2013;1(6):351–356. doi: 10.1158/2326-6066.cir-13-0151. - DOI - PMC - PubMed
1. Souza LM, Boone TC, Gabrilove J, Lai PH, Zsebo KM, Murdock DC, et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science. 1986;232(4746):61–65. doi: 10.1126/science.2420009. - DOI - PubMed
1. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood. 1991;78(11):2791–2808. doi: 10.1182/blood.v78.11.2791.2791. - DOI - PubMed

Publication types

Actions

MeSH terms

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources

[1] Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelsmann R, et al. Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci. 1985;82(5):1526–1530. doi: 10.1073/pnas.82.5.1526. - DOI - PMC - PubMed

[2] Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelsmann R, et al. Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci. 1985;82(5):1526–1530. doi: 10.1073/pnas.82.5.1526. - DOI - PMC - PubMed

[3] Welte K, Gabrilove J, Bronchud MH, Platzer E, Morstyn G. Filgrastim (r-metHuG-CSF): The first 10 years. Blood. 1996;88(6):1907–1929. doi: 10.1182/blood.V88.6.1907.bloodjournal8861907. - DOI - PubMed

[4] Welte K, Gabrilove J, Bronchud MH, Platzer E, Morstyn G. Filgrastim (r-metHuG-CSF): The first 10 years. Blood. 1996;88(6):1907–1929. doi: 10.1182/blood.V88.6.1907.bloodjournal8861907. - DOI - PubMed

[5] Metcalf D. The colony-stimulating factors and cancer. Cancer Immunol Res. 2013;1(6):351–356. doi: 10.1158/2326-6066.cir-13-0151. - DOI - PMC - PubMed

[6] Metcalf D. The colony-stimulating factors and cancer. Cancer Immunol Res. 2013;1(6):351–356. doi: 10.1158/2326-6066.cir-13-0151. - DOI - PMC - PubMed

[7] Souza LM, Boone TC, Gabrilove J, Lai PH, Zsebo KM, Murdock DC, et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science. 1986;232(4746):61–65. doi: 10.1126/science.2420009. - DOI - PubMed

[8] Souza LM, Boone TC, Gabrilove J, Lai PH, Zsebo KM, Murdock DC, et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science. 1986;232(4746):61–65. doi: 10.1126/science.2420009. - DOI - PubMed

[9] Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood. 1991;78(11):2791–2808. doi: 10.1182/blood.v78.11.2791.2791. - DOI - PubMed

[10] Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood. 1991;78(11):2791–2808. doi: 10.1182/blood.v78.11.2791.2791. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)

Affiliation

Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)

Author

Affiliation

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources